Association between complement factor H gene polymorphisms and neovascular age-related macular degeneration in koreans

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 5, 2008, Pages 2071-2076

  Kim, Na Rae ^a   Kang, Ju Hee ^a   Kwon, Oh Woong ^b   Lee, Seok Joon ^c   Oh, Jung Hyub ^a   Chin, Hee Seung ^a,d  

^a Inha University School of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Wonju Severance Christian Hospital   (South Korea)

^d Inha University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FACTOR H; GENOMIC DNA; COMPLEMENT FACTOR H, HUMAN;

ADULT; AGED; ALLELE; ARTICLE; ASIAN; CAUCASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA ISOLATION; DNA SEQUENCE; ETHNIC DIFFERENCE; EXON; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; KOREA; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RETINA EXUDATE; RETINA MACULA AGE RELATED DEGENERATION; SINGLE NUCLEOTIDE POLYMORPHISM; SUBRETINAL NEOVASCULARIZATION; CASE CONTROL STUDY; ETHNOLOGY; GENE LINKAGE DISEQUILIBRIUM; GENETICS; MIDDLE AGED; PROSPECTIVE STUDY; RETINA MACULA DEGENERATION;

AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHOROIDAL NEOVASCULARIZATION; COMPLEMENT FACTOR H; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; KOREA; LINKAGE DISEQUILIBRIUM; MACULAR DEGENERATION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES;

EID: 44649110465     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.07-1195     Document Type: Article

References (31)

1. Spaide RF, Armstrong D, Browne R. Continuing medical education review: choroidal neovascularization in age-related macular degeneration-what is the cause? Retina. 2003;23:595-614.
2. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age- related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol. 1995;39:367-374.
3. Clemons TE, Milton RC, Klein R, Seddon JM, Ferris FL 3rd. Age- Related Eye Disease Study Research Group. Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS). AREDS report no. 19. Ophthalmology. 2005;112:533-539.
4. Yates JR, Moore AT. Genetic susceptibility to age related macular degeneration. J Med Genet. 2000;37:83-87.
5. Hageman GS, Anderson DH, Johnson LV, et al. A common haplo- type in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA. 2005;102:7227-7232.
6. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science. 2005;308: 385-389.
7. Edwards AO, Ritter R 3rd, Abel KJ, et al. Complement factor H polymorphism and age-related macular degeneration. Science. 2005;308:421-424.
8. Haines JL, Hauser MA, Schmidt S, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science. 2005;308:419-421.
9. Conley YP, Thalamuthu A, Jakobsdottir J, et al. Candidate gene analysis suggests a role for fatty acid biosynthesis and regulation of the complement system in the etiology of age-related maculopa- thy. Hum Mol Genet. 2005;14:1991-2002.
10. Zareparsi S, Branham KE, Li M, et al. Strong association of the Y402H variant in complement factor H at 1q23 with susceptibility to age-related macular degeneration. Am JHum Genet. 2005;77: 149-153.
11. Magnusson KP, Duan S, Sigurdsson H, et al. CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD. PLoS Med. 2006;3:e5.
12. Sepp T, Khan JC, Thurlby DA, et al. Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers. Invest Ophthalmol Vis Sci. 2006;47:536-540.
13. Schmidt S, Hauser MA, Scott WK, et al. Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am J Hum Genet. 2006;78:852-864.
14. Rivera A, Fisher SA, Fritsche LG, et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet. 2005;14:3227-3236.
15. Grassi MA, Fingert JH, Scheetz TE, et al. Ethnic variation in AMD- associated complement factor H polymorphism p.Tyr402His. HumMutat. 2006;27:921-925.
16. Gotoh N, Yamada R, Hiratani H, et al. No association between complement factor H gene polymorphism and exudative age- related macular degeneration in Japanese. Hum Genet. 2006;120: 139-143.
17. Okamoto H, Umeda S, Obazawa M, et al. Complement factor H polymorphisms in Japanese population with age-related macular degeneration. Mol Vis. 2006;12:156-158.
18. Lau LI, Chen SJ, Cheng CY, et al. Association of the Y402H Polymorphism in complement factor H gene and neovascular age-related macular degeneration in chinese patients. Invest Oph-thalmol Vis Sci. 2006;47:3242-3246.
19. Chen LJ, Liu DT, Tam PO, et al. Association of complement factor H polymorphisms with exudative age-related macular degeneration. Mol Vis. 2006;12:1536-1542.
20. Rodriguez de Cordoba S, Esparza-Gordillo J, Goicoechea de Jorge E, Lopez-Trascasa M, Sanchez-Corral P. The human complement factor H: functional roles, genetic variations and disease associations. Mol Immunol. 2004;41:355-367.
21. Ward HM, Higgs NH, Blackmore TK, Sadlon TA, Gordon DL. Cloning and analysis of the human complement factor H gene promoter. Immunol Cell Biol. 1997;75:508-510.
22. Warwicker P, Goodship TH, Goodship JA. Three new polymorphisms in the human complement factor H gene and promoter region. Immunogenetics. 1997;46:437-438.
23. Zipfel PF, Skerka C, Hellwage J, et al. Factor H family proteins: on complement, microbes and human diseases. Biochem Soc Trans. 2002;30:971-978.
24. Wang Z, Rolish ME, Yeo G, et al. Systematic identification and analysis of exonic splicing silencers. Cell. 2004;119:831-845.
25. Li M, Atmaca-Sonmez P, Othman M, et al. CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration. Nat Genet. 2006;38: 1049-1054.
26. Ennis S, Goverdhan S, Cree A, et al. Fine-scale linkage disequilibrium mapping of age-related macular degeneration in the complement factor H gene region. Br J Ophthalmol. 2007;91:966-970.
27. DeWan A, Bracken MB, Hoh J. Two genetic pathways for age- related macular degeneration. Curr Opin Genet Dev. 2007;17: 228-233.
28. Munoz B, West SK, Rubin GS, et al. Causes of blindness and visual impairment in a population of older Americans: The Salisbury Eye Evaluation Study. Arch Ophthalmol. 2000;118:819-825.
29. Oshima Y, Ishibashi T, Murata T, et al. Prevalence of age related maculopathy in a representative Japanese population: the Hi-sayama study. Br J Ophthalmol. 2001;85:1153-1157.
30. Uyama M, Takahashi K, Ida N, et al. The second eye of Japanese patients with unilateral exudative age related macular degeneration. Br J Ophthalmol. 2000;84:1018-1023.
31. The Japanese Age-Related Macular Degeneration Trial (JAT) Study Group. Japanese age-related macular degeneration trial: 1-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Am J Ophthalmol. 2003;136: 1049-1061.